Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Influence of physicochemical factors on environmental availability and distribution of semiochemicals that affect Varroa destructor and phylogenetically close organisms: classification by VHWOC PCA-clustering.

Sánchez Pérez LC, Espinosa Montaño LG, Del Moral-Ramírez E, Ramírez-Médeles MDC, Gutiérrez-Magdaleno G, Pérez-Hernández G.

Heliyon. 2019 Aug 10;5(8):e02269. doi: 10.1016/j.heliyon.2019.e02269. eCollection 2019 Aug.

2.

Rescuing imperfect antigens for immuno-oncology.

Lorrey SJ, Sanchez-Perez L, Fecci PE.

Nat Biotechnol. 2019 Sep;37(9):1002-1003. doi: 10.1038/s41587-019-0248-2. No abstract available.

PMID:
31431731
3.

Pharmacokinetic Analysis of a Novel Human EGFRvIII:CD3 Bispecific Antibody in Plasma and Whole Blood Using a High-Resolution Targeted Mass Spectrometry Approach.

Schaller TH, Foster MW, Thompson JW, Spasojevic I, Normantaite D, Moseley MA, Sanchez-Perez L, Sampson JH.

J Proteome Res. 2019 Aug 2;18(8):3032-3041. doi: 10.1021/acs.jproteome.9b00145. Epub 2019 Jul 19.

PMID:
31267741
4.

Brain Tumor Microenvironment and Host State: Implications for Immunotherapy.

Tomaszewski W, Sanchez-Perez L, Gajewski TF, Sampson JH.

Clin Cancer Res. 2019 Jul 15;25(14):4202-4210. doi: 10.1158/1078-0432.CCR-18-1627. Epub 2019 Feb 25. Review.

PMID:
30804019
5.

Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE.

Nat Med. 2019 Mar;25(3):529. doi: 10.1038/s41591-019-0355-0.

PMID:
30670876
6.

Effective effectors: How T cells access and infiltrate the central nervous system.

Congdon KL, Sanchez-Perez LA, Sampson JH.

Pharmacol Ther. 2019 May;197:52-60. doi: 10.1016/j.pharmthera.2018.12.007. Epub 2018 Dec 14. Review.

PMID:
30557632
7.

CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response.

Riccione KA, He LZ, Fecci PE, Norberg PK, Suryadevara CM, Swartz A, Healy P, Reap E, Keler T, Li QJ, Congdon KL, Sanchez-Perez L, Sampson JH.

Oncoimmunology. 2018 Sep 5;7(12):e1502904. doi: 10.1080/2162402X.2018.1502904. eCollection 2018.

8.

Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.

Suryadevara CM, Desai R, Farber SH, Choi BD, Swartz AM, Shen SH, Gedeon PC, Snyder DJ, Herndon JE 2nd, Healy P, Reap EA, Archer GE, Fecci PE, Sampson JH, Sanchez-Perez L.

Clin Cancer Res. 2019 Jan 1;25(1):358-368. doi: 10.1158/1078-0432.CCR-18-1211. Epub 2018 Nov 13.

PMID:
30425092
9.

Promising vaccines for treating glioblastoma.

Swartz AM, Shen SH, Salgado MA, Congdon KL, Sanchez-Perez L.

Expert Opin Biol Ther. 2018 Nov;18(11):1159-1170. doi: 10.1080/14712598.2018.1531846. Epub 2018 Oct 15. Review.

PMID:
30281978
10.

Computer model for leg agility quantification and assessment for Parkinson's disease patients.

Ornelas-Vences C, Sánchez-Fernández LP, Sánchez-Pérez LA, Martínez-Hernández JM.

Med Biol Eng Comput. 2019 Feb;57(2):463-476. doi: 10.1007/s11517-018-1894-0. Epub 2018 Sep 13.

PMID:
30215213
11.

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE.

Nat Med. 2018 Sep;24(9):1459-1468. doi: 10.1038/s41591-018-0135-2. Epub 2018 Aug 13. Erratum in: Nat Med. 2019 Mar;25(3):529.

12.

Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells.

Atik AF, Suryadevara CM, Schweller RM, West JL, Healy P, Herndon Ii JE, Congdon KL, Sanchez-Perez L, McLendon RE, Archer GE, Fecci P, Sampson JH.

J Clin Neurosci. 2018 Oct;56:163-168. doi: 10.1016/j.jocn.2018.06.005. Epub 2018 Jul 21.

PMID:
30041899
13.

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma.

Suryadevara CM, Desai R, Abel ML, Riccione KA, Batich KA, Shen SH, Chongsathidkiet P, Gedeon PC, Elsamadicy AA, Snyder DJ, Herndon JE 2nd, Healy P, Archer GE, Choi BD, Fecci PE, Sampson JH, Sanchez-Perez L.

Oncoimmunology. 2018 Feb 21;7(6):e1434464. doi: 10.1080/2162402X.2018.1434464. eCollection 2018.

14.

A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis.

Swartz AM, Reap E, Norberg P, Schmittling R, Janetzki S, Sanchez-Perez L, Sampson JH.

J Immunol Methods. 2018 Aug;459:90-93. doi: 10.1016/j.jim.2018.05.015. Epub 2018 May 31.

15.

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.

Gedeon PC, Schaller TH, Chitneni SK, Choi BD, Kuan CT, Suryadevara CM, Snyder DJ, Schmittling RJ, Szafranski SE, Cui X, Healy PN, Herndon JE 2nd, McLendon RE, Keir ST, Archer GE, Reap EA, Sanchez-Perez L, Bigner DD, Sampson JH.

Clin Cancer Res. 2018 Aug 1;24(15):3611-3631. doi: 10.1158/1078-0432.CCR-17-0126. Epub 2018 Apr 27.

16.

Rest tremor quantification based on fuzzy inference systems and wearable sensors.

Sanchez-Perez LA, Sanchez-Fernandez LP, Shaout A, Martinez-Hernandez JM, Alvarez-Noriega MJ.

Int J Med Inform. 2018 Jun;114:6-17. doi: 10.1016/j.ijmedinf.2018.03.002. Epub 2018 Mar 11.

PMID:
29673605
17.

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.

Woroniecka K, Chongsathidkiet P, Rhodin K, Kemeny H, Dechant C, Farber SH, Elsamadicy AA, Cui X, Koyama S, Jackson C, Hansen LJ, Johanns TM, Sanchez-Perez L, Chandramohan V, Yu YA, Bigner DD, Giles A, Healy P, Dranoff G, Weinhold KJ, Dunn GP, Fecci PE.

Clin Cancer Res. 2018 Sep 1;24(17):4175-4186. doi: 10.1158/1078-0432.CCR-17-1846. Epub 2018 Feb 7.

18.

Dentists Survey on Adverse Events During Their Clinical Training.

Osegueda-Espinosa AA, Sánchez-Pérez L, Perea-Pérez B, Labajo-González E, Acosta-Gio AE.

J Patient Saf. 2017 Nov 4. doi: 10.1097/PTS.0000000000000296. [Epub ahead of print]

PMID:
29112027
19.

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE 2nd, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, Hossain-Ibrahim MK, Saraswathula A, Nair SK, Dunn-Pirio AM, Broome TM, Weinhold KJ, Desjardins A, Vlahovic G, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Fecci PE, Mitchell DA, Sampson JH.

Cancer Res. 2018 Jan 1;78(1):256-264. doi: 10.1158/0008-5472.CAN-17-0469. Epub 2017 Nov 1.

20.

Pronation and supination analysis based on biomechanical signals from Parkinson's disease patients.

Garza-Rodríguez A, Sánchez-Fernández LP, Sánchez-Pérez LA, Ornelas-Vences C, Ehrenberg-Inzunza M.

Artif Intell Med. 2018 Jan;84:7-22. doi: 10.1016/j.artmed.2017.10.001. Epub 2017 Oct 16.

PMID:
29042162
21.

Fuzzy inference model evaluating turn for Parkinson's disease patients.

Ornelas-Vences C, Sanchez-Fernandez LP, Sanchez-Perez LA, Garza-Rodriguez A, Villegas-Bastida A.

Comput Biol Med. 2017 Oct 1;89:379-388. doi: 10.1016/j.compbiomed.2017.08.026. Epub 2017 Aug 30.

PMID:
28866303
22.

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.

Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH.

Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057.

23.

Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles.

Sayour EJ, De Leon G, Pham C, Grippin A, Kemeny H, Chua J, Huang J, Sampson JH, Sanchez-Perez L, Flores C, Mitchell DA.

Oncoimmunology. 2016 Nov 18;6(1):e1256527. doi: 10.1080/2162402X.2016.1256527. eCollection 2017.

24.

Impact of Dental Fluorosis, Socioeconomic Status and Self-Perception in Adolescents Exposed to a High Level of Fluoride in Water.

Molina-Frechero N, Nevarez-Rascón M, Nevarez-Rascón A, González-González R, Irigoyen-Camacho ME, Sánchez-Pérez L, López-Verdin S, Bologna-Molina R.

Int J Environ Res Public Health. 2017 Jan 12;14(1). pii: E73. doi: 10.3390/ijerph14010073.

25.

Emerging immunotherapies for glioblastoma.

Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH.

Expert Opin Emerg Drugs. 2016 Jun;21(2):133-45. doi: 10.1080/14728214.2016.1186643. Review.

26.

Biological verification of sterilization cycles in dental clinics in Mexico.

Galeote-Carmona B, Sánchez-Pérez L, Acosta-Gío AE.

Am J Infect Control. 2016 May 1;44(5):613. doi: 10.1016/j.ajic.2015.09.035. Epub 2016 Feb 15. No abstract available.

PMID:
26887563
27.

Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.

Saraswathula A, Reap EA, Choi BD, Schmittling RJ, Norberg PK, Sayour EJ, Herndon JE 2nd, Healy P, Congdon KL, Archer GE, Sanchez-Perez L, Sampson JH.

Cancer Immunol Immunother. 2016 Feb;65(2):205-11. doi: 10.1007/s00262-015-1784-3. Epub 2016 Jan 12.

28.

Fluoride Exposure Effects and Dental Fluorosis in Children in Mexico City.

Molina-Frechero N, Gaona E, Angulo M, Sánchez Pérez L, González González R, Nevarez Rascón M, Bologna-Molina R.

Med Sci Monit. 2015 Nov 26;21:3664-70.

29.

Changes induced by music therapy to physiologic parameters in patients with dental anxiety.

Mejía-Rubalcava C, Alanís-Tavira J, Mendieta-Zerón H, Sánchez-Pérez L.

Complement Ther Clin Pract. 2015 Nov;21(4):282-6. doi: 10.1016/j.ctcp.2015.10.005. Epub 2015 Oct 27.

PMID:
26573456
30.

Airport take-off noise assessment aimed at identify responsible aircraft classes.

Sanchez-Perez LA, Sanchez-Fernandez LP, Shaout A, Suarez-Guerra S.

Sci Total Environ. 2016 Jan 15;542(Pt A):562-77. doi: 10.1016/j.scitotenv.2015.10.037. Epub 2015 Nov 3.

PMID:
26540603
31.

Stability of unstimulated and stimulated whole saliva flow rates in children.

Sánchez-Pérez L, Irigoyen-Camacho E, Sáenz-Martínez L, Zepeda Zepeda M, Acosta-Gío E, Méndez-Ramírez I.

Int J Paediatr Dent. 2016 Sep;26(5):346-50. doi: 10.1111/ipd.12206. Epub 2015 Oct 5.

PMID:
26437685
32.

[Comparison of varnishes and fluoridated toothpaste for the prevention of dental caries in school children].

Irigoyen-Camacho ME, Luengas-Aguirre MI, Amador-Pedraza Y, Zepeda-Zepeda MA, Villanueva-Gutiérrez T, Sánchez-Pérez L.

Rev Salud Publica (Bogota). 2015 Oct;17(5):801-814. doi: 10.15446/rsap.v17n5.48147. Spanish.

33.

Could a Factor That Does Not Affect Egg Recognition Influence the Decision of Rejection?

Ruiz-Raya F, Soler M, Sánchez-Pérez LL, Ibáñez-Álamo JD.

PLoS One. 2015 Aug 21;10(8):e0135624. doi: 10.1371/journal.pone.0135624. eCollection 2015.

34.

Are BiTEs the "missing link" in cancer therapy?

Suryadevara CM, Gedeon PC, Sanchez-Perez L, Verla T, Alvarez-Breckenridge C, Choi BD, Fecci PE, Sampson JH.

Oncoimmunology. 2015 Apr 30;4(6):e1008339. eCollection 2015 Jun. Review.

35.

Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas.

Flores C, Pham C, Snyder D, Yang S, Sanchez-Perez L, Sayour E, Cui X, Kemeny H, Friedman H, Bigner DD, Sampson J, Mitchell DA.

Oncoimmunology. 2015 Jan 22;4(3):e994374. eCollection 2015 Mar.

36.

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.

Sayour EJ, Sanchez-Perez L, Flores C, Mitchell DA.

J Immunother Cancer. 2015 Apr 21;3:13. doi: 10.1186/s40425-015-0058-0. eCollection 2015.

37.

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE 2nd, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, Sampson JH.

Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11.

38.

Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care.

Riccione K, Suryadevara CM, Snyder D, Cui X, Sampson JH, Sanchez-Perez L.

J Vis Exp. 2015 Feb 16;(96). doi: 10.3791/52397.

39.

Immunotherapy for malignant glioma.

Suryadevara CM, Verla T, Sanchez-Perez L, Reap EA, Choi BD, Fecci PE, Sampson JH.

Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S68-77. doi: 10.4103/2152-7806.151341. eCollection 2015.

40.

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence.

Johnson LA, Sanchez-Perez L, Suryadevara CM, Sampson JH.

Oncoimmunology. 2014 Jul 3;3(7):e944059. eCollection 2014.

41.

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.

Sanchez-Perez L, Suryadevara CM, Choi BD, Reap EA, Sampson JH.

Oncoimmunology. 2014 Jul 3;3(7):e944054. eCollection 2014.

42.

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.

Miao H, Choi BD, Suryadevara CM, Sanchez-Perez L, Yang S, De Leon G, Sayour EJ, McLendon R, Herndon JE 2nd, Healy P, Archer GE, Bigner DD, Johnson LA, Sampson JH.

PLoS One. 2014 Apr 10;9(4):e94281. doi: 10.1371/journal.pone.0094281. eCollection 2014.

43.

Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.

Choi BD, Gedeon PC, Herndon JE 2nd, Archer GE, Reap EA, Sanchez-Perez L, Mitchell DA, Bigner DD, Sampson JH.

Cancer Immunol Res. 2013 Sep;1(3):163. doi: 10.1158/2326-6066.CIR-13-0049.

44.

Higher prevalence of meticillin-resistant Staphylococcus aureus among dental students.

Martínez-Ruíz FJ, Carrillo-Espíndola TY, Bustos-Martínez J, Hamdan-Partida A, Sánchez-Pérez L, Acosta-Gío AE.

J Hosp Infect. 2014 Mar;86(3):216-8. doi: 10.1016/j.jhin.2013.12.007. Epub 2014 Jan 14.

PMID:
24548405
45.

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody.

Choi BD, Gedeon PC, Sanchez-Perez L, Bigner DD, Sampson JH.

Oncoimmunology. 2013 Dec 1;2(12):e26757. Epub 2013 Oct 22.

46.

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.

Sampson JH, Choi BD, Sanchez-Perez L, Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap EA, Norberg PK, Herndon JE 2nd, Kuan CT, Morgan RA, Rosenberg SA, Johnson LA.

Clin Cancer Res. 2014 Feb 15;20(4):972-84. doi: 10.1158/1078-0432.CCR-13-0709. Epub 2013 Dec 18.

47.

Drinking water fluoride levels for a city in northern Mexico (durango) determined using a direct electrochemical method and their potential effects on oral health.

Molina Frechero N, Sánchez Pérez L, Castañeda Castaneira E, Oropeza Oropeza A, Gaona E, Salas Pacheco J, Bologna Molina R.

ScientificWorldJournal. 2013 Nov 20;2013:186392. doi: 10.1155/2013/186392. eCollection 2013.

48.

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.

Choi BD, Suryadevara CM, Gedeon PC, Herndon JE 2nd, Sanchez-Perez L, Bigner DD, Sampson JH.

J Clin Neurosci. 2014 Jan;21(1):189-90. doi: 10.1016/j.jocn.2013.03.012. Epub 2013 Sep 17.

49.

[Dental fluorosis prevalence in Mexican localities of 27 states and the D.F.: six years after the publication of the Salt Fluoridation Mexican Official Regulation].

Betancourt-Lineares A, Irigoyen-Camacho ME, Mejía-González A, Zepeda-Zapeda M, Sánchez-Pérez L.

Rev Invest Clin. 2013 May-Jun;65(3):237-47. Spanish.

PMID:
23877811
50.

Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.

Choi BD, Gedeon PC, Kuan CT, Sanchez-Perez L, Archer GE, Bigner DD, Sampson JH.

J Immunol Methods. 2013 Sep 30;395(1-2):14-20. doi: 10.1016/j.jim.2013.06.003. Epub 2013 Jun 24.

Supplemental Content

Loading ...
Support Center